Renal cancer vaccine - University of Tubingen
Latest Information Update: 19 Jul 2001
At a glance
- Originator University of Tubingen
- Class Cancer vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Suspended Renal cancer
Most Recent Events
- 05 Jan 2001 Suspended-I for Renal cancer in Germany (SC)
- 19 Apr 1999 Phase-I clinical trials for Renal cancer in Germany (SC)